• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
Home » HeartWare closes $8M World Heart buyout

HeartWare closes $8M World Heart buyout

August 3, 2012 By MassDevice staff

HeartWare International
World Heart Corp.

HeartWare International (NSDQ:HTWR) said its $8 million acquisition of onetime competitor World Heart Corp. (NSDQ:WHRT) is complete.

WHRT shares stopped trading on the NASDAQ exchange when the market closed yesterday afternoon.

The companies make implantable heart pumps called ventricular assist devices. World Heart’s exit leaves Thoratec (NSDQ:THOR) and Thoratec (NSDQ:THOR) as HeartWare’s remaining rivals in the cardiac assist market.

"We are pleased with the pace of this transaction and anticipate moving quickly to integrate World Heart," HeartWare CEO Doug Godshall said in prepared remarks. "Consistent with our goal to be a leader in the VAD market for years to come, we believe that bolstering our patent portfolio and adding World Heart’s technologies broadens our options for the future."

The complex deal, announced in March, took more than a year to complete, during which time World Heart hired and fired its investment banker, was turned down by more than 16 suitors and laid off nearly all its staff. At 1 point, World Heart officials contemplated selling off all of its assets in a fire sale to pursue a reverse merger.

The deal began in earnest in March, 2011, when World Heart hired Barclays Capital to assist in exploring a potential sale to a group of large-cap and mid-to-small-cap companies.

By that time, World Heart had already paused enrollment in clinical trials of its Levacor device, a magnetically levitated, bearingless, implantable centrifugal pump, in order to make refinements to the system based on initial clinical experience.

In conversations with the FDA "it became increasingly clear that as we went down, process time lines we were hoping for were not going to be achieved and we were going to be delayed significantly," World Heart CFO Morgan Brown told MassDevice.com last summer.

Barclays contacted more than 16 potential buyers, but just HeartWare and 2 other unnamed companies agreed to explore a potential sale.

By June 6, 2011, HeartWare was the only suitor left. That company’s senior vice president and general counsel Lawrence Knopf submitted a $25 million non-binding indication of interest, but the deal soured July 12 when HeartWare, citing concerns over the Levacor trial and the company’s other projects, decided not to move forward with a merger.

For the next several weeks, as World Heart was suspending its Levacor efforts and cutting staff, officials maintained ongoing dialogue with Godshall. Those talks continued for several months with each side looking for ways to create a partnership or joint venture.

At the same time, officials at World Heart looked for ways to sell off some of the company’s more than 100 patents or the rights to intellectual property for the PediaFlow VAD program. World Heart officials explored other ways to exit the company, including selling off its intellectual property to HeartWare for $3.5 million in stock and then executing a reverse merger to a private company looking to assume World Heart’s public listing on NASDAQ.

In February 2012 World Heart laid off 77% of its workforce as it negotiated a new letter of intent from HeartWare. Those negotiations continued until the end of March when the companies announced that they had agreed to a $8 million merger, to be paid in either cash or HeartWare stock.

Filed Under: Mergers & Acquisitions, News Well, Structural Heart, Wall Street Beat Tagged With: Abiomed, HeartWare International Inc., Thoratec Corp., World Heart Corp.

More recent news

  • Aurora Spine begins first procedures with Aero lumbar fusion system
  • Caranx Medical surgical robot TaviPilot AI software wins FDA clearance
  • InspireMD launches carotid stent in U.S. after FDA approval
  • Neuros Medical raises $56M Series D to support nerve stim tech
  • CorWave reports first-in-human LVAD implant

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy